HTG Molecular Diagnostics, Inc., commonly referred to as HTG, is a pioneering company headquartered in the United States, specialising in molecular diagnostics. Founded in 2006, HTG has established itself as a leader in the development of innovative technologies for gene expression profiling and biomarker discovery, primarily serving the oncology and research sectors. The company’s flagship products, including the HTG EdgeSeq platform, offer unique solutions for high-throughput gene expression analysis, enabling precise and efficient data generation. HTG's commitment to advancing personalised medicine has positioned it favourably within the competitive landscape of molecular diagnostics, with notable achievements in enhancing patient outcomes through targeted therapies. With a strong operational presence across key regions in the US, HTG continues to drive advancements in molecular diagnostics, solidifying its reputation as a trusted partner in the healthcare industry.
How does HTG Molecular Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
HTG Molecular Diagnostics, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HTG Molecular Diagnostics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. However, as a company operating in the diagnostics industry, HTG is likely aware of the growing importance of sustainability and may be exploring avenues to enhance their environmental performance in line with industry standards.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HTG Molecular Diagnostics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.